Azenta Life Sciences has achieved a significant milestone in sterile sample storage with the launch of advanced electron-beam (E-beam) treated tubes, marking a major shift towards chemical-free sterilisation in clinical and research laboratories. This breakthrough technology addresses critical contamination challenges whilst delivering unprecedented surface treatment uniformity.

Revolutionary sterilisation approach eliminates chemical contamination risks

The innovative E-beam treatment represents a fundamental advancement in laboratory sterilisation science, offering precise, controlled surface decontamination through sophisticated radiation engineering. This cutting-edge approach eliminates the persistent challenge of chemical residuals that can compromise sample integrity in traditional sterilisation methods.

Key technical innovations:

• Uniform dose distribution technology ensuring complete surface coverage
• Chemical-free sterilisation process preventing contamination cross-transfer
• Validated Sterility Assurance Level (SAL) of 10-³ certification
• Comprehensive FluidX tube range: 0.5ml, 0.9ml, 1.0ml, 1.9ml, and 7.6ml volumes

Strategic implications for laboratory operations

This technological breakthrough complements Azenta’s established gamma irradiation capabilities, creating an unprecedented dual-sterilisation portfolio. The strategic expansion provides laboratories with optimised solutions for diverse applications – E-beam treatment for superior surface sterilisation and gamma irradiation for deep-penetration requirements. “Our expansion into E-beam treated products reflects our ongoing commitment to innovation and customer choice,” said Alexis MacLeod, Global Product Manager at Azenta Life Sciences. “This addition enhances our flexibility to support a wide range of applications whilst maintaining the high sterility standards our customers expect.”

For more information, visit: https://shorturl.at/twEtS

Digital issue: Please click here for more information